Cell signalling analyses in the functional genomics era

New Biotechnology

Volumn 30, Issue 3, 2013, Pages 333-338

  Rogne, Marie ^a,b   Taskén, Kjetil ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR SIGNALLING; FUNCTIONAL GENOMICS; HIGH-THROUGHPUT METHOD; PHOSPHOPROTEOMICS; POST-TRANSLATIONAL MODIFICATIONS; SIGNALLING COMPLEX; SIGNALLING NETWORK; SINGLE-CELL LEVEL;

ANTIBODIES; CHEMICAL COMPOUNDS; CHEMICAL DETECTION; COMPLEX NETWORKS; FLOW CYTOMETRY; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE;

CELL SIGNALING;

CELL MARKER; EPITOPE; IMATINIB; INTERLEUKIN 7; PHOSPHOPROTEIN; PROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; STAT5 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADHERENT CELL; CELL COMMUNICATION; DENDRITIC CELL; DRUG DESIGN; DRUG TARGETING; EFFECTOR CELL; FLOW CYTOMETRY; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GLIOBLASTOMA; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR SIGNALING; MASS SPECTROMETRY; MOLECULAR INTERACTION; PHOSPHOFLOW CYTOMETRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; WNT SIGNALING PATHWAY;

FLOW CYTOMETRY; GENOMICS; HUMANS; MASS SPECTROMETRY; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84878109455     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2013.01.003     Document Type: Review

References (41)

1. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
2. Hunter T., Pawson T. The evolution of protein phosphorylation. Preface. Philosophical Transactions of the Royal Society of London, Series B Biological Science 2012, 367:2512.
3. Johnson S.A., Hunter T. Kinomics: methods for deciphering the kinome. Nature Methods 2005, 2:17-25.
4. Torgersen K.M., Vang T., Abrahamsen H., Yaqub S., Tasken K. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cellular Signalling 2002, 14:1-9.
5. Irish J.M., Kotecha N., Nolan G.P. Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nature Reviews Cancer 2006, 6:146-155.
6. Cornez I., Joel M., Tasken K., Langmoen I.A., Glover J.C., Berge T. EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry. Journal of Neurooncology 2013, PMID: 23299461, [Epub ahead of print].
7. Kalland M.E., Oberprieler N.G., Vang T., Tasken K., Torgersen K.M. T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells. Journal of Immunology 2011, 187:5233-5245.
8. Christensen G.L., Kelstrup C.D., Lyngso C., Sarwar U., Bogebo R., Sheikh S.P., et al. Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Molecular and Cellular Proteomics 2010, 9:1540-1553.
9. Vermeulen M., Mulder K.W., Denissov S., Pijnappel W.W., van Schaik F.M., Varier R.A., et al. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007, 131:58-69.
10. Mann M. Functional and quantitative proteomics using SILAC. Nature Reviews Molecular Cell Biology 2006, 7:952-958.
11. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular and Cellular Proteomics 2002, 1:376-386.
12. Ong S.E., Mann M. Identifying and quantifying sites of protein methylation by heavy methyl SILAC. Current Protocols in Protein Science 2006, Chapter 14, 9.1-9.12.
13. Thiede B., Koehler C.J., Strozynski M., Treumann A., Stein R., Zimny-Arndt U., et al. Protein species high resolution quantitative proteomics of HeLa cells using SILAC-2-DE-nanoLC/LTQ-Orbitrap mass spectrometry. Molecular & Cellular Proteomics 2012, PMID: 23033477, [Epub ahead of print].
14. Druker B.J., Lydon N.B. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. Journal of Clinical Investigation 2000, 105:3-7.
15. Gambacorti-Passerini C. Part I. Milestones in personalised medicine - imatinib. Lancet Oncology 2008, 9:600.
16. Li H.M., Zeng Y.R., Chen F.X., Wu L.P., Wei F.G., Tao J., et al. Detecting phospho-signaling protein of bone marrow leukemia cells by phospho-signaling flow cytometry. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011, 19:1176-1179.
17. Nolan G.P. Deeper insights into hematological oncology disorders via single-cell phospho-signaling analysis. Hematology: American Society of Hematology. Education Program 2006, 123-127:509.
18. Oberprieler N.G., Lemeer S., Kalland M.E., Torgersen K.M., Heck A.J., Tasken K. High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8+CD45RO+ T cells. Blood 2010, 116:2253-2265.
19. Joughin B.A., Naegle K.M., Huang P.H., Yaffe M.B., Lauffenburger D.A., White F.M. An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing glioblastoma cells. Molecular Biosystems 2009, 5:59-67.
20. Naegle K.M., Welsch R.E., Yaffe M.B., White F.M., Lauffenburger D.A. MCAM: multiple clustering analysis methodology for deriving hypotheses and insights from high-throughput proteomic datasets. PLoS Computational Biology 2011, 7:e1002119.
21. Lorens J.B., Bennett M.K., Pearsall D.M., Throndset W.R., Rossi A.B., Armstrong R.J., et al. Retroviral delivery of peptide modulators of cellular functions. Molecular Therapy 2000, 1:438-447.
22. Perez O.D., Nolan G.P. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nature Biotechnology 2002, 20:155-162.
23. Perez O.D., Nolan G.P. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunological Reviews 2006, 210:208-228.
24. Perez O.D., Mitchell D., Campos R., Gao G.J., Li L., Nolan G.P. Multiparameter analysis of intracellular phosphoepitopes in immunophenotyped cell populations by flow cytometry. Current Protocols in Cytometry 2005, Chapter 6, 20.1-20.22.
25. Krutzik P.O., Nolan G.P. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nature Methods 2006, 3:361-368.
26. Bendall S.C., Simonds E.F., Qiu P., Amir E.T., Krutzik P.O., Finck R., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
27. ïrish J.M., Hovland R., Krutzik P.O., Perez O.D., Bruserud Ø., Gjertsen B.T., et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004, 118:217-228.
28. Landires I., Bugault F., Lambotte O., de Truchis P., Slama L., Danckaert A., et al. HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization. AIDS 2011, 25:1843-1853.
29. Sukhdeo K., Paramban R.I., Vidal J.G., Elia J., Martin J., Rivera M., et al. Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell lines. PLoS ONE 2013, 8:e53015.
30. Danna E.A., Nolan G.P. Transcending the biomarker mindset: deciphering disease mechanisms at the single cell level. Current Opinion in Chemical Biology 2006, 10:20-27.
31. Oberprieler N.G., Tasken K. Analysing phosphorylation-based signalling networks by phospho flow cytometry. Cellular Signalling 2011, 23:14-18.
32. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology 1999, 17:994-999.
33. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Molecular and Cellular Proteomics 2004, 3:1154-1169.
34. Koehler C.J., Strozynski M., Kozeilski F., Treumann A., Thiede B. Isobaric peptide termini labeling for MS/MS-based quantitative proteomics. Journal of proteome research 2009, 9:4333-4341.
35. Cappadona S., Munoz J., Spee W.P., Low T.Y., Mohammed S., van Breukelen B., et al. Deconvolution of overlapping isotopic clusters improves quantification of stable isotope-labeled peptides. Journal of Proteomics 2011, 74:2204-2209.
36. Munoz J., Low T.Y., Kok Y.J., Chin A., Frese C.K., Ding V., et al. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Molecular Systems Biology 2011, 7:550.
37. Germain R.N., Meier-Schellersheim M., Nita-Lazar A., Fraser I.D. Systems biology in immunology: a computational modeling perspective. Annual Review of Immunology 2011, 29:527-585.
38. 2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. Journal of Proteome Research 2008, 7:687-697.
39. Chen Y., Liu P., Hoehenwarter W., Lin J. Proteomic and phosphoproteomic analysis of Picea wilsonii pollen development under nutrient limitation. Journal of Proteome Research 2012, 11:4180-4190.
40. Mausbacher N., Schreiber T.B., Machatti M., Schaab C., Daub H. Proteome-wide analysis of temporal phosphorylation dynamics in lysophosphatidic acid-induced signaling. Proteomics 2012, 12:3485-3498.
41. Chan J.N., Nislow C., Emili A. Recent advances and method development for drug target identification. Trends in Pharmacological Sciences 2010, 31:82-88.